Cevoglitazar
Cevoglitazar (LBM-642) is a dual agonist of PPARα and PPARγ. It has demonstrated potent efficacy in reducing food consumption and body weight in preclinical studies using obese rodent and non-human primate models, supporting metabolic disease research.
Product Specifications
CAS Number
839673-52-8
Product Name Alternative
LBM 642, LBM642, LBM-642, Cevoglitazar, PPARγ, PPARα
Field of Research
Metabolism Research, Molecular Biology
Purity
97.00% (May vary between batches)
Solubility
DMSO:50 mg/mL (89.52 mM)
Smiles
S (=O) (=O) (N1C=2C (C[C@@H]1C (O) =O) =CC=CC2) C3=CC=C (OCC=4N=C (OC4C) C5=CC=C (C (F) (F) F) C=C5) C=C3
Molecular Formula
C27H21F3N2O6S
Molecular Weight
558.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog